Home Newsfeeds Barclays Maintains Underweight on Cognizant Tech Solns, Raises Price Target to $53

Barclays Maintains Underweight on Cognizant Tech Solns, Raises Price Target to $53

Barclays analyst Ramsey El-Assal maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Underweight and raises the price target from $45 to $53.

February 6, 2023

1 minute read

Barclays analyst Ramsey El-Assal maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Underweight and raises the price target from $45 to $53.

‘Lawmakers Are Already Pursuing Psychedelics Legislation In Nearly A Dozen States For 2023: From Connecticut to California, bipartisan lawmakers are signaling strong interest in reforming laws around natural plants and fungi.’ -Marijuana Moment

January 9, 3:28 PM

https://www.marijuanamoment.net/lawmakers-are-already-pursuing-psychedelics-legislation-in-nearly-a-dozen-states-for-2023/

June 22, 2:00 PM

Thoughtworks Holding (NASDAQ:TWKS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

May 21, 8:31 AM

GSK announced results from phase 3 trials SWIFT-1 and SWIFT-2, showing depemokimab's efficacy and safety in reducing severe asthma exacerbations.

April 15, 5:47 AM

This story was first published on the Benzinga India portal.